▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

Trip.com Group Q4 20 Earnings Conference Call At 7:00 PM ET

By RTTNews Staff Writer ✉ | Published: 3/4/2021 3:00 PM ET

Trip.com Group Limited (TCOM) will host a conference call at 7:00 PM ET on March 4, 2021, to discuss Q4 20 earnings results.

To access the live webcast, log on to http://investors.trip.com

For a replay call, dial +61-7-3107-6325, Passcode: 10012794.

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In June 2022

Biotech Stocks Facing FDA Decision In June 2022

Biotech Stocks Facing FDA Decision In March 2022

Biotech Stocks Facing FDA Decision In March 2022

Biotech Stocks Facing FDA Decision In February 2022 non small cell lung cancer chemotherapy

Biotech Stocks Facing FDA Decision In February 2022

Latest Updates on COVID-19

All U.S. Covid-19 Metrics Fall After Several Weeks

U.S. Schools To Get Unprecedented Resources, Tools To Reopen Safely And To Prevent Covid Spread

U.S. Covid Positive Cases And Hospitalizations Fall

U.S. Covid Cases Fall 18% In A Fortnight

CDC For A Reset To Meet New Health Threats

Read More

COVID-19: Drugs in Development

RELATED NEWS

Trip.com Gains 14% As Travel Industry Recovers

Trip.com Group Limited Q1 Earnings Summary

Trip.com Group Q1 22 Earnings Conference Call At 8:00 PM ET

Trip.com Stock Gains 7% As China Loosens Covid-19 Restrictions

Follow RTT

Editor's Pick
Most Read
Most Emailed

Foot Locker, Buckle Q2 Earnings Decline

Google Workers Petition For Equal Abortion Benefits

Apple Warns Of Security Flaws In IPhones, IPads, Macs

Hard Rock Recalls Children's Hooded Sweatshirts

FDA Warns Against Illegal Flavored Nicotine Gummies

FSIS Warns Against Hawaii Big Island Ground Beef Products

CDC For A Reset To Meet New Health Threats

Kohl's Slashes FY22 Outlook; Stock Down 7% - Update

Apple Likely To Launch IPhone 14 On Sept. 7

Lowe's, TJX Q2 Revenues Miss Estimates, But Target Revenues Met It

TJX Companies Slashes FY23 Outlook - Update

American Airlines Orders 20 Boom Supersonic Jets

Apple Likely To Launch IPhone 14 On Sept. 7

GSK: FDA Accepts New Drug Application For Momelotinib To Treat Myelofibrosis

Genentech : FDA Accepts SBLA For Polivy Combination For Aggressive Blood Cancer

AstraZeneca: FDA Grants Priority Review To SNDA For Lynparza With Abiraterone For MCRPC

FDA Approves Bluebird Bio's Gene Therapy For Rare Blood Disease

AstraZeneca: DESTINY-Breast02 Results Confirm Efficacy Seen In Previous Trials Of ENHERTU

GigaCloud Technology Prices IPO Of 2.94 Mln Class A Shares At $12.25/Class A Share

Endo Files For Chapter 11 Bankruptcy Protection

Walmart Q2 Profit Up 20%; Revenues Top Estimates

Analog Devices Q3 Profit Increases, beats estimates

ZIM Integrated Shipping Q2 Results Top Estimates

Gilead: Phase 3 TROPiCS-02 Study With Trodelvy Shows Clinically Meaningful Survival Results

Performance Food Group Q4 Profit Tops Estimates

Apple Warns Of Security Flaws In IPhones, IPads, Macs

ZIM Integrated Shipping Q2 Results Top Estimates

HeartBeam Submits 510(k) Application To FDA For AIMI Platform Technology To Diagnose Heart Attacks

Elbit Systems Q2 Adj. Net Income Declines

Horizon Enters Option Agreement With Q32 Bio To Advance ADX-914 For Autoimmune Diseases

Blend Labs, Inc Q2 Earnings Summary

Buckle Q2 Profit Down, Comps Rise - Quick Facts

Balfour Beatty H1 Profit, Orders Climb, Revenues Down; Sees FY22 Underlying Profit Ahead Of View

Walmart Q2 Profit Up 20%; Revenues Top Estimates

Walgreens Boots Alliance Sells 11 Mln Shares Of Option Care Health

Allstate Corp. Reports Estimated Catastrophe Losses For July